These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
231 related items for PubMed ID: 10659982
1. Decreased locomotor activity after microinjection of dopamine D2/D3 receptor agonists and antagonists into lobule 9/10 of the cerebellum: a D3 receptor mediated effect? Boulay D, Depoortere R, Perrault G, Sanger DJ. Prog Neuropsychopharmacol Biol Psychiatry; 2000 Jan; 24(1):39-49. PubMed ID: 10659982 [Abstract] [Full Text] [Related]
2. Dopamine D3 modulation of locomotor activity and sleep in the nucleus accumbens and in lobules 9 and 10 of the cerebellum in the rat. Barik S, de Beaurepaire R. Prog Neuropsychopharmacol Biol Psychiatry; 2005 Jun; 29(5):718-26. PubMed ID: 15913875 [Abstract] [Full Text] [Related]
4. Locomotor hypoactivity and motor disturbances--behavioral effects induced by intracerebellar microinjections of dopaminergic DA-D2/D3 receptor agonists. Kolasiewicz W, Maj J. Pol J Pharmacol; 2001 Jun; 53(5):509-15. PubMed ID: 11990070 [Abstract] [Full Text] [Related]
5. Dopamine D2 receptor knock-out mice are insensitive to the hypolocomotor and hypothermic effects of dopamine D2/D3 receptor agonists. Boulay D, Depoortere R, Perrault G, Borrelli E, Sanger DJ. Neuropharmacology; 1999 Sep; 38(9):1389-96. PubMed ID: 10471093 [Abstract] [Full Text] [Related]
8. Selective attenuation of the antinociceptive effects of mu opioids by the putative dopamine D3 agonist 7-OH-DPAT. Cook CD, Rodefer JS, Picker MJ. Psychopharmacology (Berl); 1999 Jun; 144(3):239-47. PubMed ID: 10435390 [Abstract] [Full Text] [Related]
10. Evidence for a functional role of the dopamine D3 receptors in the cerebellum. Barik S, de Beaurepaire R. Brain Res; 1996 Oct 21; 737(1-2):347-50. PubMed ID: 8930390 [Abstract] [Full Text] [Related]
13. The involvement of cerebellar dopamine D3 receptors in locomotor activity of rats. Kolasiewicz W, Maj J, Ossowska K. J Neural Transm (Vienna); 2008 May 21; 115(5):677-81. PubMed ID: 18188494 [Abstract] [Full Text] [Related]
14. Mapping the effects of the selective dopamine D2/D3 receptor agonist quinelorane using pharmacological magnetic resonance imaging. Ireland MD, Lowe AS, Reavill C, James MF, Leslie RA, Williams SC. Neuroscience; 2005 May 21; 133(1):315-26. PubMed ID: 15893653 [Abstract] [Full Text] [Related]
15. The group I metabotropic glutamate receptor antagonist S-4-CPG modulates the locomotor response produced by the activation of D1-like, but not D2-like, dopamine receptors in the rat nucleus accumbens. David HN, Abraini JH. Eur J Neurosci; 2001 Jun 21; 13(11):2157-64. PubMed ID: 11422457 [Abstract] [Full Text] [Related]
17. Nafadotride administration increases D1 and D1/D2 dopamine receptor mediated behaviors. Dall'Olio R, Gaggi R, Voltattorni M, Tanda O, Gandolfi O. Behav Pharmacol; 2002 Dec 21; 13(8):633-8. PubMed ID: 12478213 [Abstract] [Full Text] [Related]
18. Effects of a range of dopamine receptor agonists and antagonists on ethanol intake in the rat. Silvestre JS, O'Neill MF, Fernandez AG, Palacios JM. Eur J Pharmacol; 1996 Dec 30; 318(2-3):257-65. PubMed ID: 9016913 [Abstract] [Full Text] [Related]
19. Modulation of the locomotor activating effects of the noncompetitive NMDA receptor antagonist MK801 by dopamine D2/3 receptor agonists in mice. Cook CD, Newman JL, Winfree JC, Beardsley PM. Pharmacol Biochem Behav; 2004 Feb 30; 77(2):309-18. PubMed ID: 14751459 [Abstract] [Full Text] [Related]